Illumina share price drops as Roche's takeover attempts hit a wall

Article Date: 13/04/2012 10:00
Illumina share price drops as Roche's takeover attempts hit a wall

Vacancy Search

Quick job search

Advanced Search

Latest News

Vantage point – Alzheimer’s researchers urge patience and earlier-stage patients

The recent failure of Transition Therapeutics’ ELND005 could be seen as another nail in the coffin of the amyloid hypothesis in Alzheimer’s disease. But some researchers are still convinced...

Interview – Cell Therapy looks for CAR-T-like interest in heart project

Regenerating diseased heart tissue is seen as one of the best targets for stem cell therapies, and yet with hundreds of patients, and at least half a dozen types tested, no project has...

Roche's MS therapy to be filed Q1 2016

Roche's MS therapy to be filed Q1 2016

Intercept files rare liver disease drug in US, EU

Intercept files rare liver disease drug in US, EU

Boehringer diabetes drug misses endpoint

Boehringer diabetes drug misses endpoint

Celgene, Juno in 10-year, $1bn immunotherapy development deal

Celgene, Juno in 10-year, $1bn immunotherapy development deal

'Grexit' could spur drug shortages in Europe, industry fears

'Grexit' could spur drug shortages in Europe, industry fears

Widespread use of point-of-care CRP test could save UK £56m

Widespread use of point-of-care CRP test could save UK £56m

BMS immunotherapy accepted for UK early access scheme

BMS immunotherapy accepted for UK early access scheme

UK researchers develop breath test for infection

UK researchers develop breath test for infection
more news